Letter

Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease

Received:
Accepted:
Published online:

Abstract

Polycystic kidney disease (PKD) is a life-threatening disorder, commonly caused by defects in polycystin-1 (PC1) or polycystin-2 (PC2), in which tubular epithelia form fluid-filled cysts1,2. A major barrier to understanding PKD is the absence of human cellular models that accurately and efficiently recapitulate cystogenesis3,4. Previously, we have generated a genetic model of PKD using human pluripotent stem cells and derived kidney organoids5,6. Here we show that systematic substitution of physical components can dramatically increase or decrease cyst formation, unveiling a critical role for microenvironment in PKD. Removal of adherent cues increases cystogenesis 10-fold, producing cysts phenotypically resembling PKD that expand massively to 1-centimetre diameters. Removal of stroma enables outgrowth of PKD cell lines, which exhibit defects in PC1 expression and collagen compaction. Cyclic adenosine monophosphate (cAMP), when added, induces cysts in both PKD organoids and controls. These biomaterials establish a highly efficient model of PKD cystogenesis that directly implicates the microenvironment at the earliest stages of the disease.

  • Subscribe to Nature Materials for full access:

    $59

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

Accessions

Primary accessions

Gene Expression Omnibus

References

  1. 1.

    The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77, 881–894 (1994).

  2. 2.

    et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272, 1339–1342 (1996).

  3. 3.

    et al. In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. Kidney Int. 41, 1222–1236 (1992).

  4. 4.

    et al. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol. Cell 6, 1267–1273 (2000).

  5. 5.

    et al. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J. Am. Soc. Nephrol. 24, 1571–1586 (2013).

  6. 6.

    et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat. Commun. 6, 8715 (2015).

  7. 7.

    et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13, 3069–3077 (2004).

  8. 8.

    et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 103, 5466–5471 (2006).

  9. 9.

    et al. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186, 1873–1884 (1997).

  10. 10.

    , , & Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9, 1323–1326 (2003).

  11. 11.

    et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).

  12. 12.

    et al. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J. Am. Soc. Nephrol. 21, 1097–1102 (2010).

  13. 13.

    , , , & Proximal tubular cysts in fetal human autosomal recessive polycystic kidney disease. J. Am. Soc. Nephrol. 11, 760–763 (2000).

  14. 14.

    , & Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 31, 1145–1152 (1987).

  15. 15.

    et al. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum. Mol. Genet. 18, 2328–2343 (2009).

  16. 16.

    et al. Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum. Mol. Genet. 18, 2523–2531 (2009).

  17. 17.

    et al. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 17, 1578–1590 (2008).

  18. 18.

    The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81, 289–298 (1995).

  19. 19.

    et al. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum. Mol. Genet. 9, 1641–1649 (2000).

  20. 20.

    et al. Altered trafficking and stability of polycystins underlie polycystic kidney disease. J. Clin. Invest. 124, 5129–5144 (2014).

  21. 21.

    , , , & Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner. J. Clin. Invest. 125, 607–620 (2015).

  22. 22.

    et al. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney Int. 56, 1324–1333 (1999).

  23. 23.

    , , & The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87, 979–987 (1996).

  24. 24.

    et al. Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development. Am. J. Pathol. 160, 973–983 (2002).

  25. 25.

    et al. The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation. Dis Model Mech. 3, 354–365 (2010).

  26. 26.

    et al. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na+, K+,2Cl Co-transporter-dependent cystic dilation. J. Am. Soc. Nephrol. 17, 3424–3437 (2006).

  27. 27.

    et al. Tolvaptan inhibits ERK-dependent cell proliferation, Cl secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin. Am. J. Physiol. Renal Physiol. 301, F1005–F1013 (2011).

  28. 28.

    et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14, 53–67 (2014).

  29. 29.

    et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568 (2015).

  30. 30.

    et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193–1200 (2015).

  31. 31.

    et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013).

  32. 32.

    et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).

  33. 33.

    et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).

Download references

Acknowledgements

The authors thank S. Shankland, E. Kelly, D. Beier, H. Ruohola-Baker and C. Murry (UW), and J. Bonventre, J. Zhou and T. Steinman (Harvard Medical School) for helpful discussions. We thank D. Hailey (ISCRM Garvey Imaging Core) and E. Parker (UW Vision Core Lab) for microscopy support. The Laboratory of Developmental Biology was supported by NIH Award Number R24HD000836 (NICHD). Studies were supported by an NIH Career Development Award K01DK102826 (NIDDK), PKD Foundation Research Award, National Kidney Foundation Young Investigator Grant, and American Society of Nephrology Carl W. Gottschalk Research Scholar Award (B.S.F.). The work was also supported by start-up funds from the University of Washington, NIH K25HL135432 (H.F.), NIH UH3TR000504 and UG3TR002158 (J.H.), and an unrestricted gift from the Northwest Kidney Centers to the Kidney Research Institute.

Author information

Affiliations

  1. Division of Nephrology, University of Washington School of Medicine, Seattle, Washington 98109, USA

    • Nelly M. Cruz
    • , Stefan M. Czerniecki
    • , Ramila E. Gulieva
    • , Angela J. Churchill
    • , Yong Kyun Kim
    • , Kosuke Winston
    • , Linh M. Tran
    • , Marco A. Diaz
    • , Jonathan Himmelfarb
    •  & Benjamin S. Freedman
  2. Kidney Research Institute, University of Washington School of Medicine, Seattle, Washington 98109, USA

    • Nelly M. Cruz
    • , Stefan M. Czerniecki
    • , Ramila E. Gulieva
    • , Angela J. Churchill
    • , Yong Kyun Kim
    • , Kosuke Winston
    • , Linh M. Tran
    • , Marco A. Diaz
    • , Jonathan Himmelfarb
    •  & Benjamin S. Freedman
  3. Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington 98109, USA

    • Nelly M. Cruz
    • , Stefan M. Czerniecki
    • , Ramila E. Gulieva
    • , Angela J. Churchill
    • , Yong Kyun Kim
    • , Kosuke Winston
    • , Linh M. Tran
    • , Marco A. Diaz
    • , Hongxia Fu
    •  & Benjamin S. Freedman
  4. Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98109, USA

    • Nelly M. Cruz
    • , Stefan M. Czerniecki
    • , Ramila E. Gulieva
    • , Angela J. Churchill
    • , Yong Kyun Kim
    • , Kosuke Winston
    • , Linh M. Tran
    • , Marco A. Diaz
    • , Hongxia Fu
    • , Jonathan Himmelfarb
    •  & Benjamin S. Freedman
  5. Division of Nephrology, University Health Network, Toronto, Ontario M5G2N2, Canada

    • Xuewen Song
    •  & York Pei
  6. University of Toronto, Toronto, Ontario M5G2N2, Canada

    • Xuewen Song
    •  & York Pei
  7. Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98109, USA

    • Hongxia Fu
  8. Department of Bioengineering, University of Washington School of Medicine, Seattle, Washington 98109, USA

    • Hongxia Fu
  9. Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98105, USA

    • Laura S. Finn
  10. Department of Laboratories, Seattle Children’s Hospital, Seattle, Washington 98105, USA

    • Laura S. Finn

Authors

  1. Search for Nelly M. Cruz in:

  2. Search for Xuewen Song in:

  3. Search for Stefan M. Czerniecki in:

  4. Search for Ramila E. Gulieva in:

  5. Search for Angela J. Churchill in:

  6. Search for Yong Kyun Kim in:

  7. Search for Kosuke Winston in:

  8. Search for Linh M. Tran in:

  9. Search for Marco A. Diaz in:

  10. Search for Hongxia Fu in:

  11. Search for Laura S. Finn in:

  12. Search for York Pei in:

  13. Search for Jonathan Himmelfarb in:

  14. Search for Benjamin S. Freedman in:

Contributions

N.M.C., S.M.C., R.E.G., A.J.C., Y.K.K., K.W., L.M.T., M.A.D. and B.S.F. performed experiments and analysis of hPSCs and kidney organoids. X.S. and Y.P. performed global gene analysis of kidney organoid cysts. L.S.F., M.A.D. and B.S.F. analysed tissues from PKD patients. N.M.C., X.S., S.M.C., H.F., L.S.F., Y.P., J.H. and B.S.F. contributed to experimental design and analysis. B.S.F. and N.M.C. wrote the first draft of the manuscript. All authors revised the manuscript.

Competing interests

B.S.F. is an inventor on patent applications for kidney differentiation and disease modelling from human pluripotent stem cells (PCT/US14/34031, PCT/US16/50271).

Corresponding author

Correspondence to Benjamin S. Freedman.

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    Supplementary Information

Videos

  1. 1.

    Supplementary Information

    Supplementary movie 1

  2. 2.

    Supplementary Information

    Supplementary movie 2

  3. 3.

    Supplementary Information

    Supplementary movie 3

  4. 4.

    Supplementary Information

    Supplementary movie 4